We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SILC:NASDAQSilicom Ltd Analysis

Data as of 2026-09-02 - not real-time

$40.06

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Silicom Ltd. trades at $40.06, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has lost 14.4% over the past 30 days. Momentum indicators put RSI at 44.5 (neutral) with MACD reading bearish. Recent trading has carved out support near $39.68 and resistance around $52.04.
The shares look fair, trading on 166.9 times earnings above a sector average of 35.3. The average analyst target implies 49.8% above today's level. Revenue is growing at 58.5% on a -13.0% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 98.5%, a beta of 2.52 and a maximum drawdown of 31.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top Market Events

Updated Jul 29, 2026 0 \- 59% revenue growth driven by continued expansion of core business -  \- Return to quarterly...Silicom Ltd SILC accelerates growth with record Q2 revenue, seven new design wins, and an earlier-than-expected return...Silicom crushed expectations with a 33% EPS beat and 16% revenue beat, powered by a 59% year-over-year revenue surge...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 29.26
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 166.9 versus sector average of 35.3
  • Trading above the 200-day average of 29.26

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 166.9 versus sector average of 35.3
  • Negative profit margin of -13.0%
  • Analyst targets imply +49.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth58.50%
Profit Margin-12.98%
P/E Ratio166.9
ROE-8.28%
ROA-4.30%
Debt/Equity5.61
P/B Ratio2.0
Industry P/E35.3

Technical Analysis

TrendBullish
RSI44.5
Support$39.68
Resistance$52.04
MA 20$44.12
MA 50$42.82
MA 200$29.26
MACDBearish
VolumeDecreasing
Fear & Greed Index91.64

Valuation

Target Price$60.00
Upside/Downside49.78%
GradeFair
TypeGrowth

Risk Assessment

Beta2.52
Volatility98.51%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.